NOS3 rs2070779: Vascular Tone and Aerobic Performance
The rs2070779 polymorphism is an intronic single-nucleotide variant located within the NOS3 gene on chromosome 7. The gene encodes endothelial nitric oxide synthase, an essential enzyme responsible for producing nitric oxide to regulate blood vessel dilation and systemic vascular tone. Emerging research associates this variant with subtle differences in exercise-induced vasodilation and aerobic endurance capacity, though clinical evidence remains limited.
What each genotype means
Potential vascular tone variation
This genotype is associated with the NOS3 gene, which helps regulate blood vessel relaxation. Research into this specific variant suggests it may influence how your body manages vascular tone and exercise-induced vasodilation, though the evidence remains limited and findings vary across different populations. Please discuss any concerns regarding cardiovascular health or exercise performance with your healthcare provider.
This genotype is relatively rare, with the minor allele (A) occurring at a frequency of approximately 15-25% globally.
Potential vascular tone variation
This genotype is associated with the NOS3 gene, which helps regulate blood vessel relaxation. Research into this specific variant suggests it may influence how your body manages vascular tone and exercise-induced vasodilation, though the evidence remains limited and findings vary across different populations. Please discuss any concerns regarding cardiovascular health or exercise performance with your healthcare provider.
This is a common heterozygous genotype found in a significant portion of the population across various ancestries.
Typical vascular tone profile
This genotype represents the more common version of the NOS3 gene variant. While this gene is involved in nitric oxide production and vascular health, this specific genotype is generally considered the baseline in most studies. As with all genetic traits, individual health outcomes are influenced by a complex mix of genetics, lifestyle, and environment.
This is the most frequent genotype observed in the majority of global populations.
Genomic Context and the rs2070779 Variant
The single nucleotide polymorphism designated rs2070779 resides in an intronic region of the NOS3 gene, located on the long arm of chromosome 7 (7q36). While exonic variations alter protein amino acid structures directly, intronic variants frequently operate by influencing gene transcription, alternative splicing patterns, or linkage with adjacent functional regulatory regions. Research catalogs typically track the common single-base substitution between alleles at this locus, designated as G and A (or C and T depending on genomic strand reporting). Because rs2070779 is situated within non-coding sequence, its physiological influence is thought to arise from quantitative modulation of NOS3 transcript levels rather than an altered enzymatic catalytic site. In many population genetic models, it acts alongside well-known promoter and coding variants across the NOS3 locus to shape vascular phenotypes.
The Biological Role of NOS3 and Nitric Oxide
The NOS3 gene directs the synthesis of endothelial nitric oxide synthase (eNOS), a key constitutive enzyme expressed in vascular endothelial cells lining blood vessels. Using L-arginine and oxygen as primary substrates, eNOS produces nitric oxide (NO), an ephemeral gas that diffuses into vascular smooth muscle cells. Within smooth muscle, nitric oxide activates soluble guanylyl cyclase, elevating cyclic guanosine monophosphate (cGMP) and prompting vascular smooth muscle relaxation. This vasodilation regulates basal systemic blood pressure, modulates local organ perfusion, prevents leukocyte adhesion, and suppresses unwanted platelet aggregation. During physical exercise, shear stress on vessel walls normally stimulates heightened eNOS activation, providing increased blood flow and oxygen delivery to contracting skeletal muscle beds.
Research on Vascular Tone and Exercise Capacity
Candidate gene investigations in sports genomics have evaluated polymorphisms across the NOS3 locus for their potential contribution to athletic performance and cardiovascular responsiveness. Because eNOS-derived nitric oxide orchestrates exercise hyperemia and aerobic efficiency, researchers hypothesize that variants modulating NOS3 expression can influence peak oxygen uptake and endurance phenotypes. While well-studied variants like the -786T/C promoter and G894T missense mutations frequently take center stage in literature, markers such as rs2070779 have been evaluated for associations with vascular compliance, aerobic performance, and adaptation to hypoxia. However, the existing evidence for rs2070779 remains categorized as limited. Findings across athletic cohorts have frequently produced modest effect sizes or mixed results that vary depending on training background, cohort size, and co-inherited haplotype backgrounds.
Navigating Results: Actionability and Personal Health
Understanding an rs2070779 genotype provides an educational glimpse into how the vascular endothelium responds to physiological demands, but it cannot be used as a standalone diagnostic tool or athletic predictor. Physical traits like aerobic endurance and blood pressure regulation are polygenic and heavily driven by lifestyle factors, including training volume, overall nutrition, sleep, and cardiovascular fitness habits. Possessing an allele associated with altered vascular tone does not guarantee high athletic performance, nor does it establish clinical cardiovascular pathology. Readers taking cardiovascular or blood-pressure-modulating medications should never adjust pharmacological treatments based on genetic test results; any clinical decisions, dosing questions, or health assessments should always be managed directly with a qualified physician or pharmacist.
How common is this variant?
The minor A allele occurs at a frequency of approximately 0.15 to 0.25 across global reference populations, with the homozygous reference genotype (GG) representing the predominant profile worldwide.
Frequently asked questions
Does my rs2070779 genotype determine whether I can become an elite athlete?
No, an individual's athletic capability is influenced by thousands of genetic variants alongside rigorous physical training, environmental support, and nutrition. The rs2070779 variant in NOS3 has only a subtle statistical association with vascular tone and exercise traits.
Can rs2070779 testing diagnose cardiovascular disease?
No, rs2070779 is not a diagnostic marker for hypertension, heart disease, or endothelial dysfunction. Clinical cardiovascular assessments rely on physiological measurements, such as regular blood pressure screenings, lipid panels, and clinical evaluations.
How does NOS3 affect blood flow during physical exercise?
NOS3 encodes endothelial nitric oxide synthase, which synthesizes nitric oxide in response to shear stress from flowing blood. This signaling molecule relaxes the surrounding smooth muscle in blood vessels, widening them to transport oxygenated blood to working muscles.
Should I modify my cardiovascular medications based on this variant?
No, genetic trait variants such as rs2070779 must never be used to alter medication regimens. Always discuss any questions about cardiovascular therapies, blood pressure drugs, or dosage modifications with your prescribing doctor or a licensed pharmacist.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2070779?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOS3
Promoter variant (-786T>C) in the NOS3 gene associated with endothelial nitric oxide synthase expression and cardiovascular risk.
Also known as Glu298Asp (894G>T), this variant affects endothelial nitric oxide synthase cleavage and vascular tone, modulating exercise-induced vasodilation and aerobic performance.
Commonly studied variant in the endothelial nitric oxide synthase gene, associated with cardiovascular traits.
Endothelial nitric oxide synthase variant implicated in blood flow response and muscle capillarization during aerobic training.
Promoter-adjacent polymorphism affecting endothelial nitric oxide synthase transcription, modulating exercise-induced vasodilation and aerobic trainability.
The Glu298Asp variant in the NOS3 gene is associated with altered nitric oxide production and may influence susceptibility to cardiovascular conditions like hypertension and coronary artery disease.